← Back to Clinical Trials
Recruiting NCT05950282

Fasting Insulin and HOMA-IR by Age, Sex, Race/Ethnicity, BMI, and PCOS Diagnosis

Trial Parameters

Condition Insulin Resistance
Sponsor Lilli Health
Study Type OBSERVATIONAL
Phase N/A
Enrollment 500
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2024-02-01
Completion 2026-10

Brief Summary

The study aims to investigate the relationship between fasting insulin and Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) across various demographic factors, including age, sex, race/ethnicity, BMI, and polycystic ovary syndrome (PCOS) diagnosis. By analyzing these variables, the study seeks to identify potential variations in insulin levels, which could provide valuable insights into the impact of different factors on metabolic health and the development of insulin-related conditions.

Eligibility Criteria

Inclusion Criteria: * Age: Participants aged 18+ years. * Sex: Both males and females. * Race/Ethnicity: Participants from diverse racial and ethnic backgrounds * BMI: Participants with a range of body mass index (BMI) values * PCOS Diagnosis: Participants with and without a confirmed diagnosis PCOS based on established diagnostic criteria. Exclusion Criteria: * Age: Participants below 18 years * Sex: None. Both males and females are included. * Race/Ethnicity: None. Participants from all racial and ethnic backgrounds are included. * Endocrine Disorders: Participants with other endocrine disorders affecting insulin levels, such an insulin secreting tumor.

Related Trials